| Item type |
[ELS]学術雑誌論文 / Journal Article(1) |
| 公開日 |
2017-05-24 |
| タイトル |
|
|
タイトル |
Feasibility of Exploiting Celution^<TM> System in Autologous Cell Therapy in Dokkyo Medical University Hospital:Safety and Reproducibility |
|
言語 |
en |
| 言語 |
|
|
言語 |
eng |
| キーワード |
|
|
言語 |
en |
|
主題 |
Regenerative Medicine |
| キーワード |
|
|
言語 |
en |
|
主題 |
Autologous Cell Therapy |
| キーワード |
|
|
言語 |
en |
|
主題 |
Celution^<TM> System |
| キーワード |
|
|
言語 |
en |
|
主題 |
Mesenchymal Stem Cell |
| 資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
journal article |
| 雑誌書誌ID |
|
|
収録物識別子 |
AA00629581 |
| 論文名よみ |
|
|
タイトル |
Feasibility of Exploiting Celution^<TM> System in Autologous Cell Therapy in Dokkyo Medical University Hospital:Safety and Reproducibility |
| 著者 |
Inoue, Ken-ichi
Nomura, Hiroshi
Sohma, Ryoichi
Akimoto, Kazumi
Kobayashi, Naohiko
Kamai, Takao
Yamanishi, Tomonori
Taguchi, Isao
Asato, Hiroki
Inoue, Teruo
Mitsumori, Tomoyuki
Iwaguro, Hideki
Yoshida, Ken-ichiro
|
| 著者所属(英) |
|
|
|
en |
|
|
Research Support Center, Dokkyo Medical University School Of Medicine:Center For Regenerative Medicine, Dokkyo Medical University School Of Medicine |
| 著者所属(英) |
|
|
|
en |
|
|
Center For Regenerative Medicine, Dokkyo Medical University School Of Medicine:Department Of Plastic And Reconstructive Surgery, Dokkyo Medical University School Of Medicine |
| 著者所属(英) |
|
|
|
en |
|
|
Research Support Center, Dokkyo Medical University School Of Medicine:Department Of Plastic And Reconstructive Surgery, Dokkyo Medical University School Of Medicine |
| 著者所属(英) |
|
|
|
en |
|
|
Research Support Center, Dokkyo Medical University School Of Medicine:Department Of Plastic And Reconstructive Surgery, Dokkyo Medical University School Of Medicine |
| 著者所属(英) |
|
|
|
en |
|
|
Center For Regenerative Medicine, Dokkyo Medical University School Of Medicine:Department Cardiology And Nephrology, Dokkyo Medical University School Of Medicine |
| 著者所属(英) |
|
|
|
en |
|
|
Center For Regenerative Medicine, Dokkyo Medical University School Of Medicine:Department Of Urology, Dokkyo Medical University School Of Medicine |
| 著者所属(英) |
|
|
|
en |
|
|
Center For Regenerative Medicine, Dokkyo Medical University School Of Medicine:Department Of Urology, Dokkyo Medical University School Of Medicine |
| 著者所属(英) |
|
|
|
en |
|
|
Center For Regenerative Medicine, Dokkyo Medical University School Of Medicine:Department Of Cardiovascular Medicine, Dokkyo Medical University School Of Medicine |
| 著者所属(英) |
|
|
|
en |
|
|
Center For Regenerative Medicine, Dokkyo Medical University School Of Medicine:Department Of Plastic And Reconstructive Surgery, Dokkyo Medical University School Of Medicine |
| 著者所属(英) |
|
|
|
en |
|
|
Center For Regenerative Medicine, Dokkyo Medical University School Of Medicine:Department Of Cardiovascular Medicine, Dokkyo Medical University School Of Medicine |
| 著者所属(英) |
|
|
|
en |
|
|
Cytori Therapeutics Incorporation:Department Of Cardiovascular Medicine, Dokkyo Medical University School Of Medicine |
| 著者所属(英) |
|
|
|
en |
|
|
Center For Regenerative Medicine, Dokkyo Medical University School Of Medicine:Cytori Therapeutics Incorporation |
| 著者所属(英) |
|
|
|
en |
|
|
Center For Regenerative Medicine, Dokkyo Medical University School Of Medicine:Cytori Therapeutics Incorporation |
| 記事種別(英) |
|
|
内容記述タイプ |
Other |
|
内容記述 |
Original |
| 抄録(英) |
|
|
内容記述タイプ |
Other |
|
内容記述 |
In 2012, we established the Center for Regenerative Medicine in Dokkyo Medical University Hospital, and are now preparing the necessary equipment and preclinical evidence for cell therapy. Liposuction is a commonly used procedure in plastic surgery and the lipoaspirate is discarded as a medical waste. However, the lipoaspirate is known to contain abundant mesenchymal stem cells, and thus, it is currently one of the most feasible options of regenerative medicine. Several ongoing clinical trials of cell therapy (in Japan and overseas as well) are based on the Celution^ system, an automated cell-processing machine utilizing lipoaspirate. The merit of using such a machine is that collected cells are so abundant that it is not necessary to expand the cell number in a Cell Processing Center. Moreover, there are fewer risks of bacterial infection because the system is isolated from the ambient dust and operated automatically. Our group is now planning respective cell therapies for breast reconstruction after mastectomy, urinary incontinence and ischemic cardiovascular diseases, and all these protocols will be based on the Celution^ system. Here, we report the initial test run of Celution^ to confirm its safety and reproducibility. |
| 書誌情報 |
Dokkyo journal of medical sciences
巻 41,
号 1,
p. 7-12,
発行日 2014-03-25
|
| ISSN |
|
|
収録物識別子タイプ |
ISSN |
|
収録物識別子 |
03855023 |
KJ00009214761.pdf (353.6 kB)
